保险协会变化与产后处方避孕药的使用
Kimberly M Schaefer1, Michele R Hacker1, Summer S Hawkins1
1Harvard Medical School, the Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, the Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, and the School of Social Work, Boston College, Boston, Massachusetts; and the Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon.
产后保险损失降低了使用处方避孕药的可能性. 西班牙裔西班牙语人士和那些没有医疗补助扩张的州的人面临更高的保险损失率,影响避孕措施的获取.
科学领域:
- 生殖健康 生殖健康
- 医疗保健服务研究 医疗服务研究
- 卫生政策 卫生政策
背景情况:
- 产后保险流失,即分娩后失去医疗保险,是一个重大问题.
- 了解保险连续性和产后避孕之间的关系对于产妇健康结果至关重要.
研究的目的:
- 检查产后保险退出与产后避孕使用之间的关联.
- 调查种族,种族,语言和医疗补助扩展状态如何改变这种联系.
主要方法:
- 追溯队列研究使用来自42个州的怀孕风险评估监测系统 (2012-2020) 的数据.
- 后勤回归分析以根据产后保险状况确定使用处方避孕药的几率.
- 根据种族,种族,语言和医疗补助扩张状态进行分层分析,以确定差异.
主要成果:
- 保险损失产后与使用处方避孕药的几率下降26%有关 (aOR=0.74;95% CI,0.71-0.78).
- 西班牙裔西班牙语受访者产后保险损失率最高 (47.5%).
- 与扩张州相比,没有医疗补助扩张的州的受访者更有可能经历保险损失.
结论:
- 产后保险损失与减少获得处方避孕药的机会有关.
- 需要有针对性的干预和政策来解决保险中断问题,特别是在西班牙裔西班牙语人士和非医疗补助扩张州.
- 医疗补助和保险政策在确保各种人口获得公平的避孕措施方面发挥着至关重要的作用.
更多相关视频
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
相关概念视频
Birth Control Methods
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
